Clinical trial
Efficacy - Safety of Eflornithine-Nifurtimox Combination Versus Eflornithine to…
NCT00146627 · Drugs for Neglected Diseases, Other · Completed
Key facts
| NCT number | NCT00146627 |
|---|---|
| Title | Efficacy - Safety of Eflornithine-Nifurtimox Combination Versus Eflornithine to Treat Human African Trypanosomiasis |
| Official title | Clinical Study Comparing the Nifurtimox-Eflornithine Combination With the Standard Eflornithine Regimen for the Treatment of Trypanosoma Brucei Gambiense Human African Trypanosomiasis in the Meningoencephalitic Phase |
| Lead sponsor | Drugs for Neglected Diseases, Other |
| Collaborators | Medecins Sans Frontieres, Netherlands PNLTHA-DRC; PNLTHA-RoC Epicentre Swiss Tropical & Public Health Institute World Health Organization |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Trypanosomiasis, African |
| Intervention type | Drug |
| Interventions | Eflornithine, Nifurtimox |
| Enrollment | 280 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Sep 7, 2005 |
| Last update posted | Sep 29, 2016 |
| Countries | Democratic Republic of the Congo, Republic of the Congo |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: